Hiltonol (poly-ICLC) - Oncovir
Keytruda (pembrolizumab) - Merck (MSD)
IMA950 - Immatics, University Hospitals of Geneva
http://clinicaltrials.gov/ct2/show/NCT03665545
 
May 13, 2025
 
Next